The bad news is that drugmakers didn't increase global spending on marketing last year. The good news is that companies didn't cut that spending, either. But more bad news: That overall spending tab disguises some declines at the world's biggest drugmakers. The top 10 multinational drugmakers all cut their investments in marketing last year, Cegedim Strategic Data says. Report